Dynamic neuroreceptor positron emission tomography in non-anesthetized rats using point source based motion correction: A feasibility study with [ 11 C]ABP688
Restricted accessResearch articleFirst published online October, 2024
Dynamic neuroreceptor positron emission tomography in non-anesthetized rats using point source based motion correction: A feasibility study with [ 11 C]ABP688
To prevent motion artifacts in small animal positron emission tomography (PET), animals are routinely scanned under anesthesia or physical restraint. Both may potentially alter metabolism and neurochemistry. This study investigates the feasibility of fully awake acquisition and subsequent absolute quantification of dynamic brain PET data via pharmacokinetic modelling in moving rats using the glutamate 5 receptor radioligand [11C]ABP688 and point source based motion correction. Five male rats underwent three dynamic [11C]ABP688 PET scans: two test-retest awake PET scans and one scan under anesthesia for comparison. Specific radioligand binding was determined via the simplified reference tissue model (reference: cerebellum) and outcome parameters BPND and R1 were evaluated in terms of stability and reproducibility. Test-retest measurements in awake animals gave reliable results with high correlations of BPND (y = 1.08 × −0.2, r = 0.99, p < 0.01) and an acceptable variability (mean over all investigated regions 15.7 ± 2.4%). Regional [11C]ABP688 BPNDs under awake and anesthetized conditions were comparable although in awake scans, absolute radioactive peak uptakes were lower and relative blood flow in terms of R1 was higher. Awake small animal PET with absolute quantification of neuroreceptor availability is technically feasible and reproducible thereby providing a suitable alternative whenever effects of anesthesia are undesirable, e.g. in sleep research.
MoodyOAZhangERVincentKF, et al.
The neural circuits underlying general anesthesia and sleep. Anesth Analg2021;
132: 1254–1264.
2.
BenvenisteHHeerdtPMFontesM, et al.
Glymphatic system function in relation to anesthesia and sleep states. Anesth Analg2019;
128: 747–758.
3.
KiyatkinEA.The hidden side of drug action: brain temperature changes induced by neuroactive drugs. Psychopharmacology (Berl)2013;
225: 765–780.
4.
SlupeAMKirschJR.Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection. J Cereb Blood Flow Metab2018;
38: 2192–2208.
5.
NooraniBChowdhuryEAAlqahtaniF, et al.
Effects of volatile anesthetics versus ketamine on Blood-Brain barrier permeability via Lipid-Mediated alterations of endothelial cell membranes. J Pharmacol Exp Ther2023;
385: 135–145.
6.
AlstrupAKSmithDF.Anaesthesia for positron emission tomography scanning of animal brains. Lab Anim2013;
47: 12–18.
7.
SabaWGoutalSKuhnastB, et al.
Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation. Eur J Neurosci2015;
42: 1738–1745.
8.
JahreisIBascuñanaPRossTL, et al.
Choice of anesthesia and data analysis method strongly increases sensitivity of 18F-FDG PET imaging during experimental epileptogenesis. PLoS One2021;
16: e0260482.
9.
MärkJBenoitDBalasseL, et al.
A wireless beta-microprobe based on pixelated silicon for in vivo brain studies in freely moving rats. Phys Med Biol2013;
58: 4483–4500.
10.
WoodyCDzhordzhadzeVFontaineR, et al. The RatCAP conscious small animal PET tomograph. In: IEEE Symposium Conference Record Nuclear Science 2004, Rome, Italy, 2004, pp. 2334–2338. DOI: 10.1109/NSSMIC.2004.1462725.
11.
KymeAZAngelisGIEisenhuthJ, et al.
Open-field PET: Simultaneous brain functional imaging and behavioural response measurements in freely moving small animals. Neuroimage2019;
188: 92–101.
12.
KymeAZZhouVWMeikleSR, et al.
Optimised motion tracking for positron emission tomography studies of brain function in awake rats. PLoS One2011;
6: e21727.
13.
KymeASeSMeikleS, et al.
Markerless motion tracking of awake animals in positron emission tomography. IEEE Trans Med Imaging2014;
33: 2180–2190.
14.
KymeAZAksoyMHenryDL, et al.
Marker-free optical stereo motion tracking for in-bore MRI and PET-MRI application. Med Phys2020;
47: 3321–3331.
15.
KhubchandaniMMallickHNJagannathanNR, et al.
Stereotaxic assembly and procedures for simultaneous electrophysiological and MRI study of conscious rat. Magn Reson Med2003;
49: 962–967.
16.
MomosakiSHatanoKKawasumiY, et al.
Rat-PET study without anesthesia: anesthetics modify the dopamine D1 receptor binding in rat brain. Synapse2004;
54: 207–213.
17.
SungKKJangDPLeeS, et al.
Neural responses in rat brain during acute immobilization stress: a [F-18]FDG micro PET imaging study. Neuroimage2009;
44: 1074–1080.
18.
MirandaAStaelensSStroobantsS, et al.
Fast and accurate rat head motion tracking With point sources for awake brain PET. IEEE Trans Med Imaging2017;
36: 1573–1582.
19.
MirandaAKangMSBlinderS, et al.
PET imaging of freely moving interacting rats. Neuroimage2019;
191: 560–567.
20.
MirandaAGlorieDBertoglioD, et al.
Awake (18)F-FDG PET imaging of memantine-induced brain activation and test-retest in freely running mice. J Nucl Med2019;
60: 844–850.
21.
MirandaAStaelensSStroobantsS, et al.
Motion dependent and spatially variant resolution modeling for PET rigid motion correction. IEEE Trans Med Imaging2020;
39: 2518–2530.
22.
ElmenhorstDMertensKKrollT, et al.
Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain. J Sleep Res2016;
25: 754–761.
23.
AngelisGBickellMKymeA, et al. Calculated attenuation correction for awake small animal brain PET studies. In: 2013 IEEE nuclear science symposium and medical imaging conference (2013 NSS/MIC), Seoul, Korea (South), 2013, pp. 1–4. DOI: 10.1109/NSSMIC.2013.6829263.
24.
XuXXuSJinL, et al.
Characteristic analysis of otsu threshold and its applications. Pattern Recognition Letters2011;
32: 956–961.
25.
ElmenhorstDAliagaABauerA, et al.
Test-retest stability of cerebral mGluR5 quantification using [11C]ABP688 and positron emission tomography in rats. Synapse2012;
66: 552–560.
26.
ElmenhorstDMinuzziLAliagaA, et al.
In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688. J Cereb Blood Flow Metab2010;
30: 1538–1549.
27.
LammertsmaAAHumeSP.Simplified reference tissue model for PET receptor studies. Neuroimage1996;
4: 153–158.
28.
InnisRBCunninghamVJDelforgeJ, et al.
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab2007;
27: 1533–1539.
29.
LoganJFowlerJSVolkowND, et al.
Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab1996;
16: 834–840.
30.
BlandJMAltmanDG.Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat2007;
17: 571–582.
31.
GouveiaKHurstJL.Improving the practicality of using non-aversive handling methods to reduce background stress and anxiety in laboratory mice. Sci Rep2019;
9: 20305.
32.
BeerSMirandaAElmenhorstD, et al. Image quality assessment for awake animal brain PET. In: IEEE nuclear science symposium and medical imaging conference (NSS/MIC), 2019. pp. 1–3. Manchester, UK: IEEE.
33.
WyckhuysTVerhaegheJWyffelsL, et al.
N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain. J Nucl Med2013;
54: 1954–1961.
34.
SijbesmaJWAvan WaardeAVállez GarcíaD, et al.
Test-retest stability of cerebral 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) positron emission tomography (PET) in male and female rats. Mol Imaging Biol2019;
21: 240–248.
35.
AlexoffDLVaskaPMarstellerD, et al.
Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. J Nucl Med2003;
44: 815–822.
36.
KrollTElmenhorstDWeisshauptA, et al.
Reproducibility of non-invasive a1 adenosine receptor quantification in the rat brain using [(18)F]CPFPX and positron emission tomography. Mol Imaging Biol2014;
16: 699–709.
37.
DeLorenzoCMilakMSBrennanKG, et al.
In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. Eur J Nucl Med Mol Imaging2011;
38: 1083–1094.
38.
DeLorenzoCGallezotJDGardusJ, et al.
In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [(11)C]ABP688 and [(18)F]FPEB. J Cereb Blood Flow Metab2017;
37: 2716–2727.
39.
DeLorenzoCKumarJSMannJJ, et al.
In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688. J Cereb Blood Flow Metab2011;
31: 2169–2180.
40.
SandiegoCMJinXMulnixT, et al.
Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animals. J Nucl Med2013;
54: 1962–1968.
41.
TakuwaHMaedaJIkomaY, et al.
[(11)C]raclopride binding in the striatum of minimally restrained and free-walking awake mice in a positron emission tomography study. Synapse2015;
69: 600–606.
42.
RahmimADinelleKChengJC, et al.
Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events. IEEE Trans Med Imaging2008;
27: 1018–1033.
43.
Spangler-BickellMGde LaatBFultonR, et al.
The effect of isoflurane on (18)F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation. EJNMMI Res2016;
6: 86.
44.
SuzukiCKosugiMMagataY.Conscious rat PET imaging with soft immobilization for quantitation of brain functions: comprehensive assessment of anesthesia effects on cerebral blood flow and metabolism. EJNMMI Res2021;
11: 46.
45.
RakymzhanALiYTangP, et al.
Differences in cerebral blood vasculature and flow in awake and anesthetized mouse cortex revealed by quantitative optical coherence tomography angiography. J Neurosci Methods2021;
353: 109094.
46.
MuntingLPDerieppeMPPSuidgeestE, et al.
Influence of different isoflurane anesthesia protocols on murine cerebral hemodynamics measured with pseudo-continuous arterial spin labeling. NMR Biomed2019;
32: e4105.
47.
HammesJLeuwerIBischofGN, et al.
Multimodal correlation of dynamic [(18)F]-AV-1451 perfusion PET and neuronal hypometabolism in [(18)F]-FDG PET. Eur J Nucl Med Mol Imaging2017;
44: 2249–2256.
48.
MirandaABertoglioDDe WeerdtC, et al.
Isoflurane and ketamine-xylazine modify pharmacokinetics of [(18)F]SynVesT-1 in the mouse brain. J Cereb Blood Flow Metab2023;
43: 1612–1624.
49.
TétraultSCheverOSikA, et al.
Opening of the blood-brain barrier during isoflurane anaesthesia. Eur J Neurosci2008;
28: 1330–1341.
50.
DaleOJenssenU.Interaction of isoflurane with the binding of drugs to proteins in serum and liver cell cytosol. An in vitro study. Br J Anaesth1986;
58: 1022–1026.
51.
ChenYJRosarioBLMowreyW, et al.
PiB relative delivery (R1) as a proxy of relative cerebral blood flow: quantitative evaluation using single session 15O-Water and 11C-PiB PET. J Nucl Med2015;
56: 1199–1205.
52.
LorenzIHKolbitschCHörmannC, et al.
Influence of equianaesthetic concentrations of nitrous oxide and isoflurane on regional cerebral blood flow, regional cerebral blood volume, and regional mean transit time in human volunteers. Br J Anaesth2001;
87: 691–698.
53.
ReinstrupPRydingEAlgotssonL, et al.
Distribution of cerebral blood flow during anesthesia with isoflurane or halothane in humans. Anesthesiology1995;
82: 359–366.
54.
DuongTQ.Cerebral blood flow and BOLD fMRI responses to hypoxia in awake and anesthetized rats. Brain Res2007;
1135: 186–194.
